Enclosed herewith Statement of Deviation & Variation for the Quarter ended 31/03/2026
Awaiting price reaction for this filing.
Nutricircle Limited (BSE: 530219) has filed a statement confirming no deviation or variation in the utilisation of proceeds raised from a Preferential Issue. The company raised Rs. 1.10 crore (11,00,000 convertible warrants at Rs. 10 each) on 13 February 2026. The entire amount of Rs. 1.10 crore has been deployed towards stated objects including working capital, general corporate purposes, technology and machinery investments, new projects, and loan-to-equity conversion. The statement has been reviewed and approved by the Audit Committee with no comments or objections raised. The filing is in compliance with SEBI Circular CIR/CFD/CMD1/162/2019 and Regulation 32 of the SEBI (LODR) Regulations, 2015.
The filing is a routine compliance disclosure confirming proper use of funds raised via the preferential issue. No deviations reported is a positive signal indicating management adhered to stated objects, providing confidence to shareholders about fund utilisation.